Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen MacMahon

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Journal of the American Society of Nephrology : JASN|May 16, 2009
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetesToshiharu Ninomiya, Vlado Perkovic, Bastiaan E de Galan, et al.
Diabetes Care|August 5, 2009
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trialSophia Zoungas, Bastiaan E de Galan, Toshiharu Ninomiya, et al.
Journal of the American Society of Nephrology : JASN|February 20, 2009
Lowering blood pressure reduces renal events in type 2 diabetesBastiaan E de Galan, Vlado Perkovic, Toshiharu Ninomiya, et al.
European Heart Journal|June 12, 2010
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery diseaseJasper Jan Brugts, Aaron Isaacs, Eric Boersma, et al.
Journal of Hypertension|December 16, 2010
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individualsJasper J Brugts, Aaron Isaacs, Moniek Pm de Maat, et al.
The New England Journal of Medicine|June 10, 2008
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes, Anushka Patel, Stephen MacMahon, et al.
Plos One|December 10, 2016
The Effects of a Community-Based Sodium Reduction Program in Rural China - A Cluster-Randomized TrialNicole Li, Lijing L Yan, Wenyi Niu, et al.
Lancet (London, England)|September 13, 2016
Interpretation of the evidence for the efficacy and safety of statin therapyRory Collins, Christina Reith, Jonathan Emberson, et al.
The New England Journal of Medicine|September 20, 2014
Follow-up of blood-pressure lowering and glucose control in type 2 diabetesSophia Zoungas, John Chalmers, Bruce Neal, et al.
Plos Medicine|August 14, 2014
Heart failure care in low- and middle-income countries: a systematic review and meta-analysisThomas Callender, Mark Woodward, Gregory Roth, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Journal of the American Society of Nephrology : JASN|May 16, 2009
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetesToshiharu Ninomiya, Vlado Perkovic, Bastiaan E de Galan, et al.
Diabetes Care|August 5, 2009
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trialSophia Zoungas, Bastiaan E de Galan, Toshiharu Ninomiya, et al.
Journal of the American Society of Nephrology : JASN|February 20, 2009
Lowering blood pressure reduces renal events in type 2 diabetesBastiaan E de Galan, Vlado Perkovic, Toshiharu Ninomiya, et al.
European Heart Journal|June 12, 2010
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery diseaseJasper Jan Brugts, Aaron Isaacs, Eric Boersma, et al.
Journal of Hypertension|December 16, 2010
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individualsJasper J Brugts, Aaron Isaacs, Moniek Pm de Maat, et al.
The New England Journal of Medicine|June 10, 2008
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes, Anushka Patel, Stephen MacMahon, et al.
Plos One|December 10, 2016
The Effects of a Community-Based Sodium Reduction Program in Rural China - A Cluster-Randomized TrialNicole Li, Lijing L Yan, Wenyi Niu, et al.
Lancet (London, England)|September 13, 2016
Interpretation of the evidence for the efficacy and safety of statin therapyRory Collins, Christina Reith, Jonathan Emberson, et al.
The New England Journal of Medicine|September 20, 2014
Follow-up of blood-pressure lowering and glucose control in type 2 diabetesSophia Zoungas, John Chalmers, Bruce Neal, et al.
Plos Medicine|August 14, 2014
Heart failure care in low- and middle-income countries: a systematic review and meta-analysisThomas Callender, Mark Woodward, Gregory Roth, et al.
Pageof 11